Physician profile
Brian Richardson
NPI 1235897778
$1,941.70
in general payments reported to CMS, 2019-2025
15 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.83 · 2022: $496 · 2023: $624 · 2024: $481 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,386.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $662.32 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $363.41 | 2022-2024 | Caplyta |
| Vanda Pharmaceuticals INC. | $251.99 | 2022-2025 | Fanapt |
| Corium, LLC | $141.37 | 2022-2023 | Azstarys |
| Axsome Therapeutics, INC. | $121.90 | 2022-2024 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $120.58 | 2023 | Abilify Asimtufii, Abilify Maintena |
| Sunovion Pharmaceuticals INC. | $76.64 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.33 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $39.99 | 2022 | |
| Lundbeck LLC | $34.87 | 2022 | |
| Acadia Pharmaceuticals INC | $22.67 | 2022 | |
| Tris Pharma INC | $17.76 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.67 | 2022 | |
| Neos Therapeutics, LP | $16.63 | 2022 | |
| Bausch Health US, LLC | $14.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.